Latest news
April 9, 2024
New Genialis RNA biomarker accurately predicts KRAS outcomes in lung cancer patients
April 3, 2024
Merck’s M Ventures supports Nucleai’s spatial AI biomarker technology for clinical trial enrolment
April 3, 2024
Nucleai and Altis Labs are transforming clinical trials through AI innovation
February 1, 2024
VeriSIM Life Predicting Translatable Drug Combinations for ADCs – A Pharma Partner Case Study